This inventor holds 1 USPTO granted patent. Top assignee: Slayback Pharma LLC. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations by Balakrishna Reddy Akula: Revolutionizing Liquid Pharmaceutical Compositions
Introduction: Balakrishna Reddy Akula is an innovative inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly with his groundbreaking patent on liquid pharmaceutical compositions of baclofen. His work aims to enhance the availability and stability of this important medication for patients.
Latest Patents: Balakrishna Reddy Akula holds a patent for "Liquid pharmaceutical compositions of baclofen for oral administration." This invention provides stable liquid formulations of baclofen or its pharmaceutically acceptable salts at concentrations of 5 mg/mL or more. These compositions are specifically designed for oral administration and are stable at pH ranges of 5-8, which makes them suitable for long-term storage under various conditions.
Career Highlights: Currently, Balakrishna Reddy Akula is associated with Slayback Pharma LLC, where he continues to refine and develop pharmaceutical innovations. His contributions significantly impact patient care by improving the formulation and delivery of essential medications.
Collaborations: Throughout his career, Balakrishna has collaborated with notable peers, including Sushant Omprakash Dube and Girish Kumar Jain. Their collective expertise enhances research and development efforts within their organization.
Conclusion: Balakrishna Reddy Akula's work exemplifies the spirit of innovation within the pharmaceutical industry. His patent on liquid pharmaceutical compositions of baclofen not only demonstrates his ingenuity but also paves the way for advancements in patient treatment. As he continues his work at Slayback Pharma LLC, the future holds great promise for his contributions to the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
